Cord blood test reveals hidden impact of smoking on newborns

NCT ID NCT07201181

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study looks at how tobacco smoke exposure before birth—whether from active smoking or secondhand smoke—affects a newborn's health right after delivery. Researchers will measure a chemical called cotinine in the baby's cord blood to classify exposure as active, passive, or none. They will then compare health markers like blood gases, oxygen levels, and birth weight among the groups. No treatments are given; the goal is simply to gather information to better understand the risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand how tobacco smoke affects newborns, leading to improved prenatal care advice.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARBON MONOXIDE POISONING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.